SEC Form D private-offering filing

HYKU BIOSCIENCES INC.

A new SEC Form D private-offering notice from Burlington, MA, a $21,000,000 filer-stated offering target in Biotech. The source filing is one click away.

HYKU BIOSCIENCES INC. site↗ Verified via SEC Form D

Develops small molecule medicines that target histidine, tyrosine and lysine binding pockets in disease causing proteins.

Filed 2026-01-02Filed to raise $21,000,000First money in 2025-12-10Raised so far $6,600,000HQ (as filed) Burlington, MASector Biotech Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified hykubiosciences.com↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.